tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
US Market
CRDF
Cardiff Oncology
RESEARCH TOOLSreports
Want to see CRDF full AI Analyst Report?

Cardiff Oncology (CRDF) Stock News & Sentiment

1,989 Followers
Cardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
Premium
Company Announcements
Cardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
6d ago
8K
CRDF
Cardiff Oncology Wins Buy Rating on Strong Phase 2 Efficacy, FDA-Aligned Phase 3 Path, and Broader Onvansertib Combination Potential
Premium
Ratings
Cardiff Oncology Wins Buy Rating on Strong Phase 2 Efficacy, FDA-Aligned Phase 3 Path, and Broader Onvansertib Combination Potential
11d ago
CRDF
CRDF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CRDF Upcoming Earnings Report: What to Expect?
27d ago
CRDF
Cardiff Oncology appoints new CEO, CFO and COO
Premium
Company Announcements
Cardiff Oncology appoints new CEO, CFO and COO
2M ago
8K
CRDF
Cardiff Oncology Formalizes Executive Departures Amid Strategic Review
Premium
Company Announcements
Cardiff Oncology Formalizes Executive Departures Amid Strategic Review
2M ago
8K
CRDF
Cardiff Oncology advances onvansertib program in colorectal cancer
Premium
Company Announcements
Cardiff Oncology advances onvansertib program in colorectal cancer
3M ago
8K
CRDF
Cardiff Oncology: Promising Onvansertib Data and Solid Cash Runway Support Buy Rating and $10 Price Target
Premium
Ratings
Cardiff Oncology: Promising Onvansertib Data and Solid Cash Runway Support Buy Rating and $10 Price Target
3M ago
CRDF
More CRDF News >

CRDF News on the Web

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Cardiff Oncology (CRDF)
TipRanks News
Bullish
Cardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL) and Cardiff Oncology (CRDF)
TipRanks News
Bullish
Cardiff Oncology (CRDF) Gets a Buy from Piper Sandler
TipRanks News
Bullish
Cardiff Oncology (CRDF) Gets a Buy from H.C. Wainwright
TipRanks News
Bullish
Cardiff Oncology Wins Buy Rating on Strong Phase 2 Efficacy, FDA-Aligned Phase 3 Path, and Broader Onvansertib Combination Potential
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Cardiff Oncology (CRDF) and Meiragtx Holdings (MGTX)
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
CRDF
Sector Average
Media Buzz
This Week3 articles
Weekly Average2 articles
News Sentiment
This Week99%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRDF’s Media Buzz Sentiment?
3 articles about CRDF were published this week. In an average week, 2 articles are published.
    What is CRDF’s weekly average amount of articles?
    In an average week, 2 articles about CRDF are published.
      What is CRDF’s News Sentiment?
      99% of articles about CRDF were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week